Covid-19 for some organ transplant recipients, a group fearful their suppressed immune systems may leave them defenseless as pandemic restrictions end.A third of organ recipients who had no antibodies after their second dose developed them after a third dose, according to a small study reported Monday in the Annals of Internal Medicine.
The researchers also found that participants with just a small rise in their antibodies after their two-dose regimens had higher levels after they got an added shot.The results are suggestive only, coming from a 30-person observational study by Johns Hopkins University researchers.
But they were eagerly awaited in a transplant community seeking to return to normal activities as the pandemic wanes. About.